Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)

v3.23.2
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
3 Months Ended 6 Months Ended
Mar. 09, 2022
Mar. 04, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Reverse stock split description all shares adjusted to reflect a 40:1 reverse stock split the Company completed a 40:1 reverse stock split of its common shares. 40:1 Reverse Split    
Antidilutive securities, shares       820,379 675,409
Share-Based Payment Arrangement, Option [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities, shares       177,815 177,815
Warrant [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities, shares       50,000 37,083
Convertible Debt Securities [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities, shares         78,584
Conversion of Series A Stock Inclusive of Cumulative Dividends [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities, shares       244,144 110,437
Conversion of Series B Preferred Stock Inclusive of Dividends [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities, shares       348,420 271,490